Prognostic Value of Plateletcrit in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Open Access
- 1 January 2026
- journal article
- Published by T.C. Sağlık Bakanlığı Ankara Atatürk Sanatoryum Eğitim ve Araştırma Hastanesi in Sanatorium Medical Journal
- Vol. 2 (1) , 20-26
Abstract
Aim: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is an important cause for admission to the emergency departments (EDs). The search for appropriate biomarkers for the determination of prognosis in these patients is still ongoing. The prognostic value of platelet activation markers such as plateletcrit (PCT) has been shown in various inflammatory diseases. COPD acute exacerbation is a condition in which both systemic inflammation and thrombotic events occur. In this study, we aimed to investigate the prognostic value of plateletcrit, which reflects the total platelet volume in acute exacerbations of COPD. Materials and Methods: In this retrospective diagnostic/prognostic study, all patients who were admitted to the critical care area of our emergency department (ED) with COPD exacerbation were included between January 2015 and January 2020. The primary outcome (reference test) was determined as a composite outcome consisting of ICU admission and 30-day mortality. Results: 282 patients were included in our study. PCT and CRP were found to be significantly higher in patients with the composite outcome. In the ROC analysis, the area under the curve (AUC) values of PCT and CRP were found to be ; 0.975 (95% CI; 0.956 to 0.994), 0.984 (95% CI;0.972 to 0.995). Conclusion: According to our results, we think that PCT may be a good prognostic indicator in acute exacerbations of COPD, at least as much as CRP. It can provide additional information about prognosis when used together with clinical parameters.Keywords
This publication has 25 references indexed in Scilit:
- Comparison between Emergency Severity Index plus peak flow meter and Emergency Severity Index in the dyspneic patients with chronic obstructive pulmonary disease: A randomized clinical trialTurkish Journal of Emergency Medicine, 2019
- Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene CohortsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary DiseaseRespiratory Investigation, 2016
- Platelet Activation Markers Are Associated with Crohn’s Disease Activity in Patients with Low C-Reactive ProteinDigestive Diseases and Sciences, 2015
- The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary diseaseThorax, 2012
- Mean platelet volume as an indicator of disease severity in patients with acute pancreatitisClinics and Research in Hepatology and Gastroenterology, 2012
- Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPDThorax, 2011
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbationsCurrent Opinion in Pulmonary Medicine, 2009
- Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritisJoint Bone Spine, 2008